Oops! Something went wrong, please try again later.
Wave Life Sciences' alpha-1 antitrypsin deficiency candidate WVE-006 succeeded in the first-ever clinical demonstration of RNA editing in humans by …
How Will DNA Writing Help Synbio Realize Its Loftiest Ambitions?
A:
As synthetic biology grows, so too does the demand for synthetic DNA. Researchers want longer, and more complicated DNA, while not wanting to compromise on price....
Save
Share
More
